Braveheart Bio, Inc. (BRVE)
NASDAQ: BRVE · Real-Time Price · USD
25.97
-0.18 (-0.69%)
At close: Aug 13, 2026, 4:00 PM EDT
26.48
+0.51 (1.96%)
After-hours: Aug 13, 2026, 7:58 PM EDT
Braveheart Bio Market Cap
Braveheart Bio has a market cap or net worth of $1.67 billion as of August 13, 2026.
Market Cap
1.67B
Enterprise Value
1.59B
1-Year Change
n/a
Ranking
Category
Stock Price
$25.97
ChartMarket Cap Chart
Since the IPO on August 6, 2026, Braveheart Bio's market cap has increased from $1.27B to $1.67B, an increase of 31.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 1.67B | -0.69% |
| Aug 12, 2026 | 1.68B | 4.56% |
| Aug 11, 2026 | 1.60B | -9.15% |
| Aug 10, 2026 | 1.77B | -8.23% |
| Aug 7, 2026 | 1.93B | 51.37% |
| Aug 6, 2026 | 1.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.76B |
| Zymeworks | 1.76B |
| Immunocore Holdings | 1.76B |
| Ascentage Pharma Group International | 1.71B |
| Avalyn Pharma | 1.70B |
| Xencor | 1.70B |
| AnaptysBio | 1.69B |
| Intellia Therapeutics | 1.69B |